Bank Of New York Mellon Corp Fulcrum Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$2.83 - $13.99 $600,528 - $2.97 Million	212,201 New	212,201 $605 Million
Q4 2022 Feb 14, 2023	BUY	$5.01 - $8.35 $991,258 - $1.65 Million	197,856 New	197,856 $1.44 Million
Q3 2022 Nov 14, 2022	BUY	$4.92 - $9.1 $138,020 - $255,282	28,053 Added 26.87%	132,473 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$4.2 - $24.0 $15,880 - $90,744	3,781 Added 3.76%	104,420 $512,000
Q1 2022 May 11, 2022	SELL	$9.96 - $23.65 $308 - $733	-31 Reduced 0.03%	100,639 $2.38 Million
Q4 2021 Feb 11, 2022	BUY	$14.0 - $28.44 $78,946 - $160,373	5,639 Added 5.93%	100,670 $1.78 Million
Q3 2021 Nov 12, 2021	BUY	$7.28 - $30.97 $226,109 - $961,897	31,059 Added 48.55%	95,031 $2.68 Million
Q2 2021 Aug 11, 2021	BUY	$8.09 - $12.0 $175,755 - $260,700	21,725 Added 51.42%	63,972 $670,000
Q1 2021 May 13, 2021	SELL	$10.94 - $15.32 $8,369 - $11,719	-765 Reduced 1.78%	42,247 $497,000
Q4 2020 Feb 09, 2021	BUY	$7.84 - $13.4 $50,622 - $86,523	6,457 Added 17.66%	43,012 $503,000
Q3 2020 Nov 12, 2020	BUY	$7.22 - $20.7 $33,508 - $96,068	4,641 Added 14.54%	36,555 $289,000
Q2 2020 Aug 12, 2020	SELL	$9.11 - $22.06 $12,653 - $30,641	-1,389 Reduced 4.17%	31,914 $583,000
Q1 2020 May 06, 2020	BUY	$9.49 - $21.26 $316,045 - $708,021	33,303 New	33,303 $397,000

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $237M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.